News

We are delighted to announce that Allegrow has signed a memorandum of understanding (MOU) with...

We're going back to ASGH this year on our home turf with our alma mater. Laurence and our BD...

We're heading to Dublin for ISCT 2026! Fariza and Joel will be presenting our latest work —...

We are pleased to announce that Allegrow Biotech has been selected for Precision Medicine P4...

We'll be at ELRIG Cell & Gene Therapy 2026 at Hinxton Hall, Cambridge, UK on March 9-10. The...

We are honored to have been awarded 3rd place at the EQT Impact Challenge Hong Kong 2025,...

We're excited to announce that our team of Laurence (co-founder, CEO), Ying (co-founder) and Joel...

In our previous article, we explored the morphological changes that T cells undergo upon...

Allegrow Biotech Limited (煥境生物科技有限公司) has been awarded 𝐭𝐡𝐞 𝟑𝐫𝐝 𝐇𝐊𝐒𝐏𝐀 𝟐𝟎𝟐𝟑-𝟐𝟎𝟐𝟒 𝐁𝐢𝐨𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐏𝐢𝐨𝐧...

T cells, also known as T lymphocytes, are central components of the adaptive immune system. They...

When it comes to T cell activation and expansion, researchers are spoilt for choice when it comes...

We’re kicking off the year with fantastic news—Allegrow Biotech has been selected as one of the...

Allegrow is celebrating EC's 25th birthday next week! If you are back on the campus of the Hong...

We are pleased to announce that Allegrow Biotech has secured investment from HKUST E-Fund, our...

Catch us in Singapore next week! We are super excited to make it into the final 50 startups for...

We are excited to share a key milestone for Allegrow Biotech, as we are selected for the Incubio...

We are exhilarated to share that Allegrow has emerged triumphant as the Winner at Jumpstarter...

We are thrilled to be invited by HKUST Entrepreneurship Center to participate in 2023 Asia Summit...

Wonderful news! Allegrow was awarded with Gold Medal in 2023 48th Geneva International Exhibition...

We are thrilled to announce that Allegrow is one of the Technology Start-up Support Scheme for...